Invizius Company

Invizius is developing treatments to help hemodialysis patients live longer, feel better, and suffer fewer cardiovascular complications.
“Despite significant improvements in the quality and efficacy of hemodialysis therapy in recent years, cardiovascular disease (CVD) remains the leading cause of death for dialysis patients. Today, almost half of all dialysis patients die from cardiovascular complications, and life expectancy on dialysis is just one-third of normal. With its proprietary H-Guard™ technology, Invizius is addressing the side effects of hemodialysis to help patients feel better, and suffer fewer cardiovascular complications.”
Technology: Other
Industry: Preventive Medicine
Headquarters: Edinburgh, Edinburgh, City of, United Kingdom
Founded Date: 2017
Employees Number: Undisclosed
Funding Status: Seed

Visit Website
Register and Claim Ownership